Provided by Tiger Trade Technology Pte. Ltd.

Elevance Health

345.84
-0.9601-0.28%
Volume:369.40K
Turnover:127.95M
Market Cap:76.33B
PE:13.72
High:352.00
Open:347.41
Low:343.61
Close:346.80
52wk High:458.75
52wk Low:273.71
Shares:220.70M
Float Shares:220.70M
Volume Ratio:0.54
T/O Rate:0.17%
Dividend:6.84
Dividend Rate:1.98%
EPS(TTM):25.21
EPS(LYR):25.21
ROE:13.25%
ROA:4.35%
PB:1.74
PE(LYR):13.72

Loading ...

Elevance Health Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 13

Humana Loss Was Less Than Expected. Why the Stock Is Falling. -- Barrons.com

Dow Jones
·
Feb 11

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

Dow Jones
·
Feb 11

Market Chatter: Elevance, CVS, Other Insurers Subpoenaed by House Committee Over ACA Subsidy Fraud Probe

MT Newswires Live
·
Feb 10

Republican-led US House panel issues subpoenas to eight health insurers, Axios reports

Reuters
·
Feb 10

Elevance Health Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Feb 10

Growth Investors: Industry Analysts Just Upgraded Their Elevra Lithium Limited (ASX:ELV) Revenue Forecasts By 12%

Simply Wall St.
·
Feb 08

Der effektive Einkommensteuersatz von Elevance Health sank im Gesamtjahr 2025 auf 15,6 Prozent (minus 8,9 Prozentpunkte)

Reuters
·
Feb 07

Elevance Health posts FY 2025 effective income tax rate of 15.6%, down 8.9 percentage points

Reuters
·
Feb 07

Centene sees 2026 profit above estimates signaling stabilizing costs

Reuters
·
Feb 06

Elevance Health Refocuses On Government Plans And Shareholder Returns

Simply Wall St.
·
Feb 06

Health Insurers Tumble. Molina Healthcare Forecasts 2026 Profit Below Estimates as Costs Weigh

Reuters
·
Feb 06

Elevance Health Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Feb 06

Cigna beats quarterly estimates, provides muted outlook

Reuters
·
Feb 05

Wall Street's Top Analysts Issue Latest Ratings: Adobe Downgraded, Palantir Upgraded

Deep News
·
Feb 03

Guggenheim Adjusts Elevance Health Price Target to $414 From $398, Maintains Buy Rating

MT Newswires Live
·
Feb 03

Elevance Health : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $358 From $392

THOMSON REUTERS
·
Feb 03

Assessing Elevance Health (ELV) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Feb 03

Elevance Health Is Maintained at Overweight by JP Morgan

Dow Jones
·
Feb 03

Elevance Health Is Maintained at Buy by Truist Securities

Dow Jones
·
Feb 02